Skip to main content
ES
v1.2
Log in
P

Piramal Pharma

PIRAMAL PHARMANSE
₹197.73+3.30 (+1.70%)as of 2026-10-16
Market Cap
₹26,346Cr.
P/E Ratio
—
P/B Ratio
3.22
EPS (TTM)
—
Day Range
₹193.6 – ₹198.75
Div Yield
0%
ROCE
2.52%
ROE
-3.83%
52W Low: ₹13252W High: ₹232
Themes:💊 Pharma & CDMO
Descriptive screens built from published data — not investment advice.

At a glance

  • Sales have grown 8.0% a year over three years.
  • Debt is 0.70× its shareholders’ equity.

From reported financials and exchange prices. Descriptive only, not advice.

Piramal_Pharma — Price
Interval
||
Style
Failed: 503

Evenstocks Score

Middle third
4.5/ 10Overall
5/ 10Valuation
3/ 10Quality
5/ 10Fundamental
5/ 10Growth

Investment Checklist

Quick assessment based on key parameters
Performance
N/ATrailing return unavailable
Valuation
N/AP/E: N/A | P/B: 3.22
Growth
ModestSales CAGR — 3Y: 8% · 1Y: 1%
Profitability
Low MarginROCE: 2.52% | ROE: -3.83%

Key Metrics

Valuation
Price / Sales 2.86x
Price / FCF 34.0x
Book Value ₹61.4
Margins & returns
Operating Margin 11%
Net Margin -3.4%
Return on Assets -1.8%

Frequently Asked Questions

MarketsPortfolioChart